Gerresheimer AG

06.04.2023 – 07:00
Gerresheimer with a good start to 2023 financial year: Again double-digit growth in revenues and Adjusted EBITDA
Düsseldorf (ots) - - First-quarter revenues grew organically by 21.0% - Adjusted EBITDA up organically by 24.8% - Gerresheimer confirms guidance for financial year 2023 Gerresheimer AG, a leading provider of healthcare & beauty solutions and drug ...
Ein Dokument
mehr
23.02.2023 – 07:00
Gerresheimer 2022: Profitable growth company boosting revenue and adjusted EBITDA growth to double-digit levels
Duesseldorf (ots) - - Consistent execution of strategy and strong fourth quarter performance has resulted in organic revenue growth of 16.2% for FY 2022 - Organic growth in adjusted EBITDA of 10.2% for FY 2022, ahead of guidance - Q4 2022 delivered ...
Ein Dokument
mehr
06.12.2022 – 16:00
Gerresheimer to expand significantly in High Value Solutions and further accelerates its sustainable profitable growth
Düsseldorf (ots) - At today’s Capital Markets Day, Gerresheimer AG, a leading provider of healthcare & beauty solutions and drug delivery systems for pharma, biotech and cosmetics, reaffirmed its growth agenda and increased its revenue and adjusted ...
Ein Dokument
mehr